ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 633253 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 633253; 2) Community: the network communities that were significantly associated with the response to NSC 633253; 3) Molecule: the relationships between components within communities and NSC 633253; 4) MDR: the compounds that were significantly associated with the NSC 633253.

NSC Compound Enrichment Correlation
NSC 665549 Azoxydapsone {1,2-bis-[4-(4'-aminophenylsulfonylphenyl)]- diazine-1-oxide} 0.0291420747327559 0.50735233
NSC 672120 Oxireno[9,10]cyclodeca[1,2-b]furan-6,9(7H,10aH)-dione, 1a,2,3,7a,8,10b-hexahydro-1a,5-dimethyl-8-methylene-, stereoisomer 0.0291420747327559 -0.29931471
NSC 712572 1,2 Benzo-8-(1-hydroxy-2-methylamino propane)-3-phenoxazone 0.0291420747327559 -0.012551583
NSC 742036 Null 0.0291420747327559 0.68673534
NSC 670694 Null 0.029142074732756 -0.059184171
NSC 676532 Ether-20 0.029142074732756 0.016602595
NSC 726217 Combretastatin A4-analogue 0.029142074732756 -0.09607003
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.029142074732756 0.084241298
NSC 40273 Null 0.0295480456086945 0.18321755
NSC 618939 Camptothecin Derivative 0.0295480456086945 0.27072533
Total:63  Current:36    [First] [Prev] [Next] [Last]